-
Market Wrap For February 27: Yellen Talks Pushes Markets Higher
Thursday, February 27, 2014 - 5:47pm | 2887Read More...U.S. stocks rose after Federal Reserve boss Janet Yellen appeared in the hot-seat today speaking to the Committee on Financial Services and U.S. House of Representatives. Yellen said that it is too soon to determine the extent of which cold weather played a role in a recent batch of poor economic...
-
Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff
Tuesday, January 14, 2014 - 6:19pm | 2515Read More...Major indices reversed Monday's losses and posted strong gains following a better than expected retail sales report and a luke-warm start to earnings season. Related: Stocks Higher, But Dollar Indecisive After Retail Sales Release Philidalphia's Fed chief Charles Plosser said that he wants QE...
-
Barron's Recap (3/2/12): Wealth Managers See Calmer Seas Ahead
Sunday, March 3, 2013 - 6:31pm | 864Read More...This weekend in Barron's online: a Penta asset-allocation survey, the Dow ready to hit a record high, and the prospects for Barnes & Noble, Danone, Forestar Group and Asian markets. Cover Story "More Stocks, Fewer Bonds" by Karen Hube. After years of investing defensively, the largest...
-
Perrigo Earnings Preview
Monday, August 15, 2011 - 9:55am | 601Read More...Perrigo (NASDAQ: PRGO) is scheduled to report fourth-quarter fiscal 2012 results Tuesday morning, August 16. Jim Cramer called this health care products maker the “best knock-off company known to man” and said he expects it report a good quarter. The consensus forecast has Perrigo posting...
-
Citi Maintains Buy on Mylan
Monday, June 27, 2011 - 7:30am | 128Read More...Citi is out with its report today on Mylan (NYSE: MYL), maintaining Buy. In a note to clients, Citi writes, "We rate the shares of Mylan Buy/High Risk (1H) with a $29 target. Mylan currently trades at the low end of its historical average forward P/E multiple, however, the company is generating...
-
Goldman Sachs Maintains Buy on Mylan Inc. (MYL)
Wednesday, March 9, 2011 - 10:08am | 95Read More...Goldman Sachs is out with its report this morning on Mylan Inc. (NASDAQ: MYL), maintaining Buy after meeting with management. In a note to clients, Goldman Sachs writes, "Near-term path remains attractive with 1Q a low hurdle in our view and a more active launch pipeline in 2011 likely to instill...
-
Buy Rating Reiterated On MYL
Wednesday, October 27, 2010 - 6:52am | 159Read More...Citigroup has issued a research report on Mylan Inc. (NASDAQ: MYL) following 3Q earnings results. In the report, Citigroup writes "MYL expects sequential growth in Europe after a weak 3Q10, and no significant impact of FX fluctuations. MYL continues to benefit from limited competition generic...
-
Mylan Launches Generic Version Of Wellbutrin
Wednesday, October 6, 2010 - 7:18am | 175Read More...Citigroup has issued a research report for Mylan, Inc. (NASDAQ: MYL) following the launch of generic formulations of Wellbutrin for smoking cessation. In the report, Citigroup writes "Generic Wellbutrin XL is another of MYL's 12 limited competition generic launches expected in 2010, with IMS...
-
Goldman Adds Mylan To CL-Buy List
Thursday, September 23, 2010 - 8:27am | 131Read More...Goldman Sachs writes "[We] are adding Mylan Inc. (NASDAQ: MYL) to the CL-Buy list with 42% upside to our 12-month $26 price target. While we were early in our Buy recommendation post 1Q, we continue to see 2H2010 as an inflection point and expect a reversal in recent share weakness on (1)...
-
Citigroup Raises Estimates For Mylan
Friday, September 10, 2010 - 8:13am | 113Read More...Mylan, Inc. (NASDAQ: MYL) has had its 2010/2011/2012 EPS estimates raised by Citigroup to $1.67/1.97/2.20 (from $1.64/1.83/2.09) as a result of the completion of the Bioniche acquisition and launch of generic Solodyn and Catapres TTS on 9/7, Citigroup reports. Sales estimates for Mylan have also...
